To Dr Boiler and Dr Snoball
Thanks for your replies, if CVac is ultimately found to be equally or better suited to treatment of ovarian cancer in its early stages then the PRR sp will take off and go through the roof. With potential massive upside, a good stock to hold for those not adverse to taking a calculated risk as a small part of their share portfolio.
Stagman
ovplex - ovarian cancer diagnostic test , page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $569.8M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $1.746M | 4.422M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7395 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 94636 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |